By 2023, all of Johnson & Johnson's facilities in the United States, Canada, and Europe will use only renewable energy, marking a significant step toward the company's climate ambitions

Published on: 30 November 2021
jnj 093020

Johnson & Johnson has signed a power purchase agreement (PPA) in the U.S., accelerating its target to use 100% renewable electricity by 2025. Johnson & Johnson aims to source 100% of its U.S. and Canadian electricity from wind and solar by 2023.

The new agreement will be comprised of a solar array in Southern Texas for a total generation capacity of 55 megawatts (MW) or approximately 117,000 megawatt hours (MWh) of renewable electricity annually. The agreement was signed in coordination with Ørsted, and the solar installation is currently being built.

This adds to existing on-site and off-site renewable projects that currently provide about 70% of Johnson & Johnson’s electricity needs in the U.S. and Canada. Additionally, the Company announced a deal earlier in the year for solar power at its Jacksonville, Florida facility. Johnson & Johnson Vision’s production site in Limerick, Ireland is already powered by wind, so when the Jacksonville project comes online in 2022 all ACUVUE® Brand contact lenses are expected to be made using 100% renewable electricity.

“Last year we announced our most ambitious climate goals to date, including an accelerated renewable electricity goal. We are wasting no time making progress because we know there is no time to waste – the world needs bold climate action to advance both human and planetary health,”

said Paulette Frank, Chief Sustainability Officer, Johnson & Johnson.

This North America deal follows the completion of three PPAs in Europe for wind and solar installations, announced in July, that are expected to take Johnson & Johnson to the equivalent of 100% renewable electricity for all operations in Europe by 2023[2].

Johnson & Johnson has a longstanding commitment to environmental health, including two decades of setting and achieving public climate commitments. Johnson & Johnson’s current Health for Humanity Climate Goals are to source 100% of the Company’s electricity from renewable sources by 2025, to achieve carbon neutrality in its global operations by 2030 and to reduce upstream, value chain (Scope 3) emissions by 20% by 2030 (from 2016 levels).

To date, the Company has built over 50 on-site renewable energy systems on properties in 14 countries and has executed 15 deals for off-site renewable electricity procurement. At the end of 2020, 54% of Johnson & Johnson’s global electricity came from renewable sources.

Read more about Johnson & Johnson’s Health for Humanity Goals here.

Johnson & Johnson is also a proud signatory of the Race to Zero/ Business Ambition for 1.5°C campaign with an ambition to reach net zero carbon emissions across its value chain by 2045.

About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities, and forward progress. That’s why, for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body, and environment within reach of everyone, everywhere. We are blending our heart, science, and ingenuity to profoundly change the trajectory of health for humanity. Learn more at www.jnj.com. Follow us at @JNJNews.

Source: jnj news

Share:
esg
esg
esg
esg
More from Johnson & Johnson
Johnson & Johnson names Honeywell's CEO to its board
Johnson & Johnson names Honeywell's CEO to its board
Johnson & Johnson is a 2022 Fortune World's Most Admired Company and pharmaceutical industry leader
Johnson & Johnson is a 2022 Fortune World's Most Admired Company and pharmaceutical industry leader
Providing an Award-Winning Diversity and Inclusion Model
Providing an Award-Winning Diversity and Inclusion Model